Benzimidazoles, compositions containing such compounds and methods of use

Details for Australian Patent Application No. 2004238240 (hide)

Owner Merck & Co., Inc.

Inventors Kim, Ronald M.; Liang, Rui; Rouse, Elizabeth Ashley; Parmee, Emma R.; Chapman, Kevin T.; Chang, Jiang

Agent Spruson & Ferguson

Pub. Number AU-A-2004238240

PCT Pub. Number WO2004/100875

Priority 60/469,332 09.05.03 US

Filing date 5 May 2004

Wipo publication date 25 November 2004

International Classifications

A61K 031/415 - 1,2-Diazoles

Event Publications

3 November 2005 PCT application entered the National Phase

  PCT publication WO2004/100875 Priority application(s): WO2004/100875

21 February 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004238241-1- (2h-pyrazol -3-yl) -3yl) {4-`1- (benzoyl) - piperidin-4-ylmethyl!-phenyl}-urea derivatives and related compounds as inhbitors of p38 kinase and/or TNF inhibitors for the treatment of imflammations

2004238239-Oral care tablet